Hospice News and Research

RSS

Penn Medicine awarded $22 million to apply scientific solutions to reverse opioid crisis

The nation has been grappling with the opioid epidemic for years-;and the city of Philadelphia has been hit hard by the crisis. While data is showing slight declines in overdose deaths, the opioid crisis remains a public health emergency.

4 Oct 2019

Penn researchers propose ethical framework that defines brain organoid transplantation

As research involving the transplantation of human "mini-brains"--known as brain organoids--into animals to study disease continues to expand, so do the ethical debates around the practice.

4 Oct 2019

Study shows how caregivers can better manage family conflict at end of life

Conflict within families can be stressful and confusing, and it can lead to feelings of sadness. It also is incredibly common and in many cases, a necessary part of family dynamics.

3 Oct 2019

Penn researchers win NIA grant to study link between Alzheimer's, dementia, and Parkinson's

The Center for Neurodegenerative Disease Research (CNDR) at the University of Pennsylvania has received a grant expected to total $18.1 million to study the underlying genetic mechanisms that cause Alzheimer's Disease, Dementia, and Parkinson's Disease to progress as well as how those mechanisms are related to each other and to the cell-to-cell spread of these disease proteins.

30 Sep 2019

Prediction system found to be effective at increasing palliative care consultations

Palliative Connect, a trigger system developed at Penn Medicine and powered by predictive analytics, was found to be effective at increasing palliative care consultations for seriously ill patients, according to a new study from researchers in the Perelman School of Medicine at the University of Pennsylvania.

25 Sep 2019

Oncologists respond quickly to emerging FDA safety data for drugs, study finds

Within six months of the U.S. Food and Drug Administration's move to restrict the label of two immunotherapies, usage of those therapies among oncologists dropped by about 50 percent, according to a new study from researchers in the Abramson Cancer Center at the University of Pennsylvania.

24 Sep 2019

Penn researchers develop novel vaccine to protect against genital herpes

Researchers from the Perelman School of Medicine at the University of Pennsylvania have developed a vaccine to protect against genital herpes.

20 Sep 2019

Knowing when and how to taper off opioid dosage crucial to safe pain management

Many healthcare providers today try to avoid administering or prescribing opioid pain medications when possible because of the narcotics' addictive properties. But for some patients, opioid medications remain the most effective, most appropriate treatment for their subjective pain complaints.

20 Sep 2019

Early palliative care linked to better survival in patients with advanced lung cancer

Early palliative care is associated with better survival in patients with advanced lung cancer, according to a study by VA Portland Health Care System and Oregon Health and Science University researchers.

19 Sep 2019

Patients with non-Hodgkin's lymphoma may benefit from radiation, experience reduced side effects

Treating non-Hodgkin's lymphoma patients with radiation therapy as an additional treatment while they wait for their CAR T cells to be manufactured may reduce the risk of CAR T therapy side effects once it is administered, according to a new study from researchers in the Abramson Cancer Center at the University of Pennsylvania.

18 Sep 2019

Text messaging, electric pill bottles not enough to drive down blood pressure levels

About one in three Americans have high blood pressure, called hypertension, but only about half of them have their condition under control.

18 Sep 2019

UK’s leading anti-euthanasia campaign group responds to 'misleading and irresponsible' film

Care Not Killing, the UK’s leading anti-euthanasia campaign group, responds to the “misleading and irresponsible” campaign film, published earlier this month by Dignity in Dying.

13 Sep 2019

CAR T-cell therapy may be viable treatment option for heart disease

CAR T-cell therapy, a rapidly emerging form of immunotherapy using patients' own cells to treat certain types of cancers, may be a viable treatment option for another life-threatening condition: heart disease.

12 Sep 2019

UA receives $1.4 million grant for a peer-support program to help sleep apnea patients

University of Arizona College of Medicine - Tucson Professor Sairam Parthasarathy, MD, has been awarded nearly $1.4 million for a peer-support program for sleep apnea patients.

3 Sep 2019

Research reveals family perceptions of end-of-life care for patients with advanced CKD

In patients with advanced chronic kidney disease (CKD), receiving high intensity care before death was linked with lower family satisfaction with care, while receiving palliative and hospice care was associated with greater family satisfaction.

30 Aug 2019

French organ transplant centers more likely to accept kidneys discarded in the United States

French organ transplant centers are far more likely to accept "lower-rated" kidneys, like those from older organ donors, than centers in the United States, according to a first-of-its kind analysis published today in JAMA Internal Medicine.

26 Aug 2019

New therapy found to be effective for patients with a particular type of bone marrow cancer

Mount Sinai researchers have found a new type of therapy to be effective for patients with a particular type of bone marrow cancer that is resistant to several standard therapies, according to results of a clinical trial published in The New England Journal of Medicine in August.

22 Aug 2019

Study identifies key epigenetic regulator that controls skin cell turnover

The outer layer of the skin completely replaces itself every two to four weeks, but when this process is blocked, cancer can grow.

21 Aug 2019

New Recommendation Statement for BRCA1/2 evaluation still fails to address many problems

The U.S. Preventive Services Task Force has released a new Recommendation Statement for BRCA1/2 evaluation, urging the medical community to widen the parameters used to assess BRCA1 and BRCA2 mutation risks and increase the use of genetic counseling and testing for those with the highest risk.